The new ruling adds mounting pressure on Mexican lawmakers, who, despite the legalization of medical cannabis in 2017, have not created a pathway for patient access.
The report indicates that the National Institute for Health Research should prioritize research on cannabis-based products in five areas, including chronic pain in children and young people.
Curaleaf lobbied on more state bills than any other cannabis company as the session came to a close.
Possible winners? Workers in Uruguay and Colombia, and patients in Europe. Possible losers? Adult use consumers in Uruguay, who face a shortage.
The administration announced priority licensing for large-scale business projects to ramp up economic growth in the country.
Four years after the law opened the gates, the first tinctures will hit pharmacies Tuesday. It’s been a long journey.
But the conservative politician pushing the measure says that’s as far as it goes.
Cannabis Wire has learned that the global company is now lobbying in at least three states.
In the wake of a major report on all aspects of cannabis policy, the prime minister moves to relax the rules.
NY’s Southern Tier is “well on its way to becoming the Silicon Valley of industrial hemp,” Sen. Chuck Schumer said Monday.